Synchronous medullary carcinoma of the pancreas and non-ampullary duodenal adenocarcinoma
Abstract
Synchronous primary malignancies involving the pancreas and duodenum are rare and distinguishing them from direct extension or metastatic spread may be difficult in the periampullary region. We report a 73-year-old man who initially presented with upper gastrointestinal bleeding and was later investigated for weight loss, abdominal pain, dyspepsia, and abnormal liver biochemistry. Preoperative imaging and biopsy identified poorly differentiated adenocarcinoma involving the pancreatic and duodenal region, but the relationship between the lesions remained uncertain. Following pancreaticoduodenectomy, two macroscopically separate tumor sites were identified. Histological examination showed that the pancreatic tumor had features of medullary carcinoma, including syncytial growth, pushing borders, marked lymphocytic infiltration, and mismatch repair deficiency. In contrast, the duodenal tumor showed glandular differentiation, infiltrative invasion, and desmoplastic stroma, but also deficient mismatch repair. Lymph node involvement was seen with the pancreatic tumor but not the duodenal lesion. This case suggested that synchronous primary tumors should remain in the differential diagnosis when adjacent periampullary lesions show discordant pathological features, and that definitive classification may require integration of gross examination, morphology, selected immunohistochemistry, mismatch repair status, and nodal disease pattern on the resection specimen. The underlying diagnosis of Lynch syndrome provides a novel pathogenesis for these genetically related yet distinct tumors. This diagnosis was important not only for understanding tumor pathogenesis but also for ongoing surveillance and family counselling.
##plugins.themes.bootstrap3.article.details##
Synchronous carcinoma, Medullary carcinoma of the pancreas, Duodenal carcinoma, immunohistochemistry, molecular testing, periampullary tumor, mismatch repair deficiency, synchronous primary malignancy
2. Yago A, Furuya M, Mori R, et al. Medullary carcinoma of the pancreas radiologically followed up as a cystic lesion for 9 years: a case report and review of the literature. Surg Case Rep. 2018 Jul 24;4(1):80. doi: 10.1186/s40792-018-0487-3. PMID: 30043132; PMCID: PMC6057860.
3. Verocq C, Racu ML, Bafort D, et al. Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report. Diagn Pathol. 2021 Dec 13;16(1):117. doi: 10.1186/s13000-021-01178-0. PMID: 34895278; PMCID: PMC8667442.
4. Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol. 2000 May;156(5):1641-51. doi: 10.1016/S0002-9440(10)65035-3. PMID: 10793075; PMCID: PMC1876921.
5. Cloyd JM, George E, Visser BC. Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg. 2016 Mar 27;8(3):212-21. doi: 10.4240/wjgs.v8.i3.212. PMID: 27022448; PMCID: PMC4807322.
6. Meijer LL, Alberga AJ, de Bakker JK, et al. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018 Sep;25(9):2681-2692. doi: 10.1245/s10434-018-6567-6. Epub 2018 Jun 26. PMID: 29946997; PMCID: PMC6097725.
7. Eriguchi N, Aoyagi S, Hara M, et al. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases. Surg Today. 2000;30(8):718-21. doi: 10.1007/s005950070083. PMID: 10955735.
8. Kim SH. Metachronous pancreatic cancer 18 years after resection of common bile duct cancer: A case report. Front Surg. 2022;9:851524. doi:10.3389/fsurg.2022.851524 PubMed PMID: 36090324; PubMed Central PMCID: PMC9448957.
9. Du Y, Duan Y, Zhang L, et al. A Female With Synchronous Multiple Primary Malignant Tumors in the Esophagogastric Junction, Duodenum and Pancreas: Case Report and Review of the Literature. Front Oncol. 2022 May 30;12:890587. doi: 10.3389/fonc.2022.890587. PMID: 35707359; PMCID: PMC9190262.
10. Shin SJ, Park H, Sung YN, et al. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only. Cancer Res Treat. 2018 Oct;50(4):1175-1185. doi: 10.4143/crt.2017.494. Epub 2017 Dec 20. PMID: 29268568; PMCID: PMC6192923.
11. Lee YP, Lee JS, Kim HS, et al. Synchronous pancreatic adenocarcinoma and duodenal mucosa‑associated lymphoid tissue lymphoma: A case report. Medicine (Baltimore). 2024 Dec 27;103(52):e41173. doi: 10.1097/MD.0000000000041173. PMID: 39969306; PMCID: PMC11688084.
12. Hirai R, Omae K-ichi, Yodoya M, et al. A case report of a collision tumor composed of pancreatic ductal adenocarcinoma and peri-pancreatic mucosa-associated lymphoid tissue lymphoma. World J Surg Onc. 2023 Mar 28;21(1):110. doi:10.1186/s12957-023-02981-3
13. Izumi H, Furukawa D, Yazawa N, et al. A case study of a collision tumor composed of cancers of the bile duct and pancreas. Surg Case Rep. 2015 Dec;1(1):40. doi: 10.1186/s40792-015-0041-5. Epub 2015 May 9. PMID: 26943405; PMCID: PMC4747933.
14. Sastry A, Wayne M, Steele J, et al. Three synchronous, sporadic and separate periampullary and pancreatic tumors: more than a coincidence? World J Surg Oncol. 2014 Dec 13;12:382. doi: 10.1186/1477-7819-12-382. PMID: 25494951; PMCID: PMC4301858.
15. Ohtsubo K, Sato S, Sakaguchi H, et al. Case Report: Medullary carcinoma of the pancreas with MLH1 promoter hypermethylation, induced deficient mismatch repair, successfully treated with an immune checkpoint inhibitor. Front Oncol. 2025 Mar 27;15:1551038. doi: 10.3389/fonc.2025.1551038. PMID: 40236650; PMCID: PMC11997870.
16. Ahadova A, Gallon R, Gebert J, et al. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Int J Cancer. 2018 Jul 1;143(1):139-150. doi: 10.1002/ijc.31300. Epub 2018 Feb 23. PMID: 29424427.
17. Ye JX, Liu Y, Qin Y, et al. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. World J Gastroenterol. 2015 Feb 7;21(5):1595-605. doi: 10.3748/wjg.v21.i5.1595. PMID: 25663779; PMCID: PMC4316102.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.
https://orcid.org/0009-0009-1085-6316